Sign in
Ben...

Ben...

Senior Equity Research Analyst at Stephens Inc. /ar/

Atlanta, GA, US

Ben is a Senior Equity Research Analyst at Stephens Inc., specializing in coverage of regional banks and financial institutions. He closely follows companies such as Hancock Whitney Corporation, providing in-depth analysis and investment recommendations that have contributed to positive returns and recognition by investors. Ben joined Stephens Inc. after accumulating several years of experience in financial analysis, having previously held roles at other major firms within the banking sector. He holds FINRA registration and maintains securities licenses that validate his expertise in equity research and financial markets.

Ben...'s questions to HUNTINGTON BANCSHARES INC /MD/ (HBAN) leadership

Question · Q3 2025

Ben inquired about the drivers behind Huntington Bancshares' deposit pricing outperformance and the expected deposit beta over the next 100 basis points of rate cuts. He also sought clarification on the 10 basis points of NIM expansion for next year, specifically if it's on a full-year basis and if fixed-rate repricing is the biggest driver.

Answer

CFO Zach Wasserman attributed deposit outperformance to exceptional execution by deposit teams on both rate and volume, underpinned by primary bank relationships and sophisticated analytical approaches, with a 40% beta observed in recent rate cuts. He confirmed the 10 basis points of NIM expansion is on a full-year basis for 2026, with fixed asset repricing being the most significant driver, stemming from lower roll-off yields compared to new production yields, and noted the company's asset-neutral position buffers rate scenarios.

Ask follow-up questions

Ben...'s questions to ABBNY leadership

Question · Q1 2025

Ben, via the online portal, asked for clarification on the portfolio change, specifically whether the Machine Automation business will become a separate division within Process Automation.

Answer

CEO Morten Wierod confirmed that Machine Automation will be moved into Process Automation as a separate division. He noted its performance is improving and it will continue to collaborate on projects across ABB, contributing its PLC and automation solutions where relevant, such as in the energy and infrastructure industries.

Ask follow-up questions

Ben...'s questions to MYRIAD GENETICS (MYGN) leadership

Question · Q4 2024

Ben..., on behalf of Jason Deuchler, asked for commentary on the market reception of the Prequel launch at 8 weeks and sought confirmation of guidance for double-digit hereditary cancer testing volume growth in 2025.

Answer

CEO Paul Diaz reported that while it's still early, there has been significant excitement from providers for the 8-week Prequel launch because it aligns with the first patient visit and improves clinical workflows. He then clarified that the company does not provide guidance for specific product volumes, though management has previously discussed expectations for stable overall ASPs.

Ask follow-up questions

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%